Glycogen storage disease due to acid maltase deficiency, late-onset
MONDO:0018485Glycogen storage disease due to acid maltase deficiency, late onset (AMDL), a form of Glycogen storage disease due to acid maltase deficiency (AMD), a degenerative metabolic myopathy particularly affecting respiratory and skeletal muscles, is characterized by an accumulation of glycogen in lysosomes.
Also known as: Alpha-1,4-glucosidase acid deficiency, late onset, Alpha-1,4-glucosidase acid deficiency, late-onset, GSD due to acid maltase deficiency, late onset, GSD due to acid maltase deficiency, late-onset, GSD type 2, late onset, GSD type 2, late-onset, GSD type II, late onset, GSD type II, late-onset
28 clinical trials for this condition and its sub-types, 19 tagged with Glycogen storage disease due to acid maltase deficiency, late-onset itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Can an oral pill ease breathing and muscle weakness in pompe disease?
Disease control Not yet recruitingThis early-stage trial is testing an experimental oral medication called S-606001 in adults with late-onset Pompe disease, a condition that causes progressive muscle weakness and breathing problems. The main goal is to see if the drug is safe and tolerable. Researchers will also …
Phase 1 • Sponsor: Shionogi • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Can an oral pill boost muscle strength in pompe disease?
Disease control Not yet recruitingThis study tests the long-term safety and effectiveness of an experimental oral drug called S-606001 in adults with late-onset Pompe disease, a genetic condition that causes progressive muscle weakness. Participants who completed a prior S-606001 study can join, and they will rec…
Phase 2 • Sponsor: Shionogi • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC